Keyphrases
Primary Liver Transplantation
100%
Immunosuppression
100%
Tacrolimus
100%
Orthotopic Liver Transplantation
55%
Acute Rejection
44%
Malignancy
44%
Graft Loss
44%
Hypertension
22%
Cardiovascular Events
22%
Patient Survival Rate
22%
Age Groups
11%
Liver Transplant Recipients
11%
Renal Function
11%
Long-term Efficacy
11%
Survivors
11%
FK506
11%
Monotherapy
11%
Diabetes
11%
End-stage Renal Disease
11%
Dialysis
11%
Consecutive Patients
11%
Patient Survival
11%
Pediatric Patients
11%
Most Common Cause
11%
Kidney Transplantation
11%
Mortality Rate
11%
Graft Survival
11%
Recurrent Disease
11%
Cause of Death
11%
Morbidity Rate
11%
Single Center
11%
Hyperkalemia
11%
Lymphoproliferative Disorders
11%
Long-stay Patients
11%
Retransplantation
11%
Long-term Safety
11%
Steroid Responsive
11%
Non-insulin-dependent Diabetes Mellitus (NIDDM)
11%
Late Follow-up
11%
Long-term Morbidity
11%
Infection Recurrence
11%
Long-term Mortality
11%
Immunology and Microbiology
Liver Transplantation
100%
Immunosuppression
100%
Tacrolimus
100%
Transplant Procedure
54%
Survival Rate
27%
Acute Graft Rejection
27%
Kidney Function
9%
Kidney Transplantation
9%
Mortality Rate
9%
Chronic Graft Rejection
9%
Lymphoproliferative Disorders
9%
Morbidity
9%
Pharmacology, Toxicology and Pharmaceutical Science
Tacrolimus
100%
Graft Failure
36%
Survival Rate
27%
Acute Graft Rejection
27%
Disease
18%
Recurrent Disease
18%
Mortality Rate
9%
Infection
9%
Morbidity
9%
Monotherapy
9%
Hyperkalemia
9%
Insulin Dependent Diabetes Mellitus
9%
End Stage Renal Disease
9%
Chronic Graft Rejection
9%
Biochemistry, Genetics and Molecular Biology
Survival Rate
100%
Kidney Function
33%
Mortality Rate
33%
Morbidity
33%
Hyperkalemia
33%